Related Experiment Video

Updated: May 4, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.6K

Prevalence and characteristics of depressive disorders in type 1 diabetes

Line Iden Berge1, Trond Riise, Oivind Hundal

  • 1Haukeland University Hospital, Division of Psychiatry/Institute of Clinical Medicine, Section of Psychiatry, University of Bergen, Bergen, Norway. line.iden.berge@gmail.com.

BMC Research Notes
|December 21, 2013
PubMed

Insights

Depressive disorders are common in type 1 diabetes patients. While not statistically significant, higher HbA1c levels were observed in those with depression, suggesting a potential link.

Area of Science:

  • Endocrinology
  • Psychiatry
  • Clinical Medicine

Background:

  • Diabetes and depression co-occurrence increases risks for complications and mortality.
  • Understanding depressive disorders in type 1 diabetes is crucial for patient outcomes.

Purpose of the Study:

  • To investigate the prevalence of depressive disorders in type 1 diabetes patients.
  • To examine clinical characteristics and impact on glycosylated hemoglobin (HbA1c).

Main Methods:

  • Utilized the Mini International Neuropsychiatric Interview (M.I.N.I) for diagnosis.
  • Assessed 51 type 1 diabetes outpatients for dysthymia and depressive episodes.
  • Measured HbA1c and collected family history data.

Main Results:

  • 16% of patients had a major depressive episode; 6% had dysthymia; 12% had previous depression.
  • 33% had ongoing or previous depressive disorders.
  • Elevated HbA1c (8.5%) in depressed patients compared to non-depressed (7.9%), though not statistically significant.

Conclusions:

  • High prevalence of depressive disorders, including melancholia, observed in type 1 diabetes patients.
  • No statistically significant difference in diabetes regulation (HbA1c) between depressed and non-depressed groups was found.
Abstract

More Related Videos

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

2.2K
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

16.3K

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.3K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17